Ketkar, Amita https://orcid.org/0000-0002-9287-0868
Willey, Vincent
Glasser, Lisa
Dobie, Casey
Wenziger, Cachet
Teng, Chia-Chen
Dube, Christine
Hirpara, Sunny
Cunningham, Dennis
Verduzco-Gutierrez, Monica
Funding for this research was provided by:
AstraZeneca United States
Article History
Received: 21 September 2023
Accepted: 28 November 2023
First Online: 13 January 2024
Declarations
:
: Christine Dube, Lisa Glasser, and Sunny Hirpara are employees and shareholders of AstraZeneca. Monica Verduzco-Gutierrez has received honoraria and travel to give lectures related to long COVID-19; unrelated to this work, she has been a consultant with AbbVie (consultant/advisor, speakers bureau), Merz (consultant/advisor, speakers bureau), Ipsen (grant/research, consultant/advisor, speakers bureau), Medtronic (consultant/advisor), and Piramal (speakers bureau). Dennis Cunningham has been a consultant/advisor for AstraZeneca. Dennis Cunnigham had an affiliation with Henry Ford Health, Detroit, MI, USA at the time of study which has changed since to Michigan State University, MI, USA. Carelon Research received funding from AstraZeneca to conduct this study. Amita Ketkar, Vincent Willey, Cachet Wenziger, and Chia-Chen Teng are employees of Carelon Research (formerly known as HealthCore). Amita Ketkar and Vincent Willey are shareholders of Elevance Health (formerly Anthem), which is the parent company of Carelon Research (formerly HealthCore). Casey Dobie is an employee of Xcenda, a Cencora company, and a consultant for AstraZeneca.
: Ethics committee approval was not required for this study. All data were accessed as a limited data set for which a business associate and data use agreement was in place with the covered entities in compliance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. All protected health data were deidentified and thus exempt from institutional review board review.